DMAA (Tag Archives)

Subscribe to PricePlow's Newsletter and DMAA Alerts

Topic Blog Posts YouTube Videos Instagram Posts
DMAA

Dan Fabricant (NPA): Why You Need to Show Up in Washington DC | Episode #100

Dan Fabricant: NPA's 2023 Washington DC Fly-In Day for Episode #100 on the PricePlow Podcast

https://blog.priceplow.com/podcast/dan-fabricant-npa-2023-washington-dc

For Episode 100 of the PricePlow Podcast, Ben and Mike flew to Washington D.C. for the Natural Products Association’s annual DC Fly-In Day on June 7, 2023. Fly-in days, also known as “lobby days”, bring individuals together to advocate with legislators and other officials on behalf of their shared interests.

So this was […]
Continue Reading →

Published on by in , , , | No Comments

Melatonin and CBD Under Fire? Meet Pieter Cohen, the Grim Reaper of ‘Gray Area’ Ingredients

Melatonin CBD Pieter Cohen FDA

The Journal of the American Medicine Association (JAMA) recently published a study showing that the quality control on melatonin gummies in the United States may not be the best – unfortunately, only 12% of the products tested were FDA compliant.[1]

Reason being, the FDA generally allows a discrepancy of up to 10% between a product’s […]
Continue Reading →

Published on by in | No Comments

DMAA Banned From Supplements: Hi-Tech Pharmaceuticals Loses Appeal

DMAA Banned

Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.

This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.

On August […]
Continue Reading →

Published on · Updated by in , | 14 Comments

Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma

Hi-Tech DMAA Confiscation Overturned

All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.

We finally have a bit of an update, but it’s important to stress that Hi-Tech is still under an order from Judge Alan Braverman […]
Continue Reading →

Published on by in | 4 Comments

DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court

Hi-Tech DMAA Lawsuit Appeal

In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:

Hi-Tech appealed the ruling of district court judge Willis B. Hunt because he made his decision against them based upon information that neither[…]
Continue Reading →

Published on by in | 2 Comments

Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)

Hi-Tech DMAA FDA Lawsuit Appeal

Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.

This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.

BREAKING (August […]
Continue Reading →

Published on · Updated by in , | 6 Comments

Hi-Tech Fights to Get its Confiscated DMAA Back (December 2017)

Hi-Tech Pharmaceuticals vs. FDA Update May 3, 2019: A judge ordered the US Government to return Hi-Tech’s seized DMAA (see “Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma“), but it was ultimately for naught since Hi-Tech Lost the DMAA case.

Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to […]
Continue Reading →

Published on by in , | 131 Comments

Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??

May 3, 2019 Update: Although Hi-Tech still can’t sell it due to the agreement discussed below, the US Government has been ordered to return the DMAA that was wrongfully confiscated in the below proceedings.

November 15, 2017 Update: Hi-Tech has filed a motion to amend the terms agreed to in this indictment (ie. they’re fighting […]
Continue Reading →

Published on by in , | No Comments

Is Angelo Lisi’s Geranium Study the WEAKEST Study Ever Published?

Angelo Lisi Australia DMAA Geranium Study

This is part five of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.

In our previous article, we explored how the FDA wasted $2.3 million dollars on a study where researchers Mahmoud […]
Continue Reading →

Published on by in , | No Comments

Mahmoud ElSohly & Ikhlas Khan’s $2.3 Million FDA Tax Waste: Incomplete Results Published

Ikhlas Khan DMAA Multi Center Study - An FDA Tax Waste

This is part four of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.

Given the rancid stench emanating from the previous two disastrous studies discussed on this blog (1. Mahmoud ElSohly and […]
Continue Reading →

Published on by in | No Comments